Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 105 participants.
Also called NCT02742129
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 105 participants
- Sponsor
- Registry
-
NCT02742129
-
- Other papers using this trial's data
- Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02742129. Randomized; triple masking; primary purpose treatment. Start 2016-08-10 (actual); primary completion 2017-12-13 (actual). Results posted on 2019-03-13.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
- Acronym
- INDIE-HFpEF
- Condition
- Heart Failure
- Intervention (Drug)
- Nebulized Sodium Nitrite
- Intervention (Drug)
- Placebo
- Lead sponsor
- Adrian Hernandez
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
- Collaborator
- Aires Pharmaceuticals, Inc.
- Collaborator
- University of Vermont
- Collaborator
- Université de Montréal
- Collaborator
- Mayo Clinic
- Collaborator
- Massachusetts General Hospital
Record details
- Record id
cardio:ct-nct02742129- Content hash
3b9524e2af596f1df618c5a27e00f8767b7164f324b23b1d57e017dfef29fbad